SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009014
Filing Date
2016-11-02
Accepted
2016-11-02 08:01:18
Documents
66
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alks-20160930x10q.htm 10-Q 2129599
2 EX-10.1 alks-20160930ex101cbe0d4.htm EX-10.1 96333
3 EX-10.2 alks-20160930ex10298781f.htm EX-10.2 1799028
4 EX-31.1 alks-20160930ex3114fb626.htm EX-31.1 47468
5 EX-31.2 alks-20160930ex312363984.htm EX-31.2 47567
6 EX-32.1 alks-20160930ex321f1ac7e.htm EX-32.1 21132
  Complete submission text file 0001558370-16-009014.txt   9100745

Data Files

Seq Description Document Type Size
7 EX-101.INS alks-20160930.xml EX-101.INS 1648088
8 EX-101.SCH alks-20160930.xsd EX-101.SCH 36557
9 EX-101.CAL alks-20160930_cal.xml EX-101.CAL 67718
10 EX-101.DEF alks-20160930_def.xml EX-101.DEF 98878
11 EX-101.LAB alks-20160930_lab.xml EX-101.LAB 390522
12 EX-101.PRE alks-20160930_pre.xml EX-101.PRE 256412
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35299 | Film No.: 161966352
SIC: 2834 Pharmaceutical Preparations